Home › Stocks › INO › All Fund Holders
INO — INOVIO PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 31 · Reported value held: $29.47M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 8.45M | $9.30M | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 3.31M | $5.77M | 0.00% | Hold |
| Vanguard Group history | Q4 2025 | 3.32M | $5.77M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 1.35M | $1.49M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 1.24M | $1.36M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 802.75K | $883.75K | 0.00% | Hold |
| Millennium Management history | Q2 2026 | 796.11K | $875.72K | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 779.06K | $856.96K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 645.48K | $710.02K | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 361.34K | $397.47K | 0.00% | Reduce |
| Wellington Management Group history | Q3 2024 | 65.63K | $379.36K | 0.00% | New |
| Balyasny Asset Management history | Q1 2024 | 22.25K | $308.77K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 262.32K | $288.55K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 174.39K | $191.83K | 0.00% | Reduce |
| BNY Mellon history | Q1 2025 | 75.42K | $122.94K | 0.00% | Add |
| Amundi US history | Q1 2024 | 11.61K | $118.38K | 0.00% | New |
| AQR Capital Management history | Q2 2025 | 53.17K | $108.20K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 93.72K | $103.09K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 80.34K | $88.37K | 0.00% | New |
| Manulife Financial history | Q2 2024 | 10.17K | $82.17K | 0.00% | New |
| Deutsche Bank AG history | Q1 2025 | 39.02K | $63.61K | 0.00% | Reduce |
| Bank of America Corp history | Q1 2026 | 32.68K | $56.86K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 50.26K | $55.28K | 0.00% | Reduce |
| Citigroup Inc history | Q3 2025 | 12.98K | $30.37K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q3 2025 | 12.33K | $28.85K | 0.00% | Add |
| Marshall Wace history | Q1 2026 | 13.19K | $22.95K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 3.26K | $3.59K | 0.00% | Add |
| Legal & General Investment Management America history | Q1 2025 | 2.20K | $3.58K | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 300 | $330 | 0.00% | Hold |
| JPMorgan Chase & Co history | Q2 2026 | 46 | $52 | 0.00% | New |
| T. Rowe Price Associates history | Q1 2025 | 15.60K | $26 | 0.00% | New |